Market Trends Axsome reports mixed results for Alzheimer’s agitation drugBy admin8996erT0allDecember 30, 2024 IvelinRadkovAxsome Therapeutics (NASDAQ:AXSM) stock fell 12% Monday after the company reported mixed Phase 3 results for its drug AXS-05, or…
